Sartorius Closes TAP Bisystems Acquisition

Sartorius, a leading international laboratory and pharmaceutical equipment provider, successfully completed its acquisition of UK companyTAP Biosystems Group plc towards the end of last year.

The cash offer made through Sartorius’ wholly owned subsidiary Sartorius Stedim Biotech of approximately €33 million had been approved byTAP Biosystems’ shareholders on November 21, 2013.

The acquisition will enable Sartorius to further extend its bioprocess portfolio in the area of fermentation, especially in the early phases of product and process development. Founded in 1987, the company is headquartered Royston, UK, generated sales revenue of approximately €26 million in 2012/2013 and employs around 160 people worldwide.